dronabinol has been researched along with arachidonyl-2-chloroethylamide in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (63.64) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gynther, J; Järvinen, T; Lahtela-Kakkonen, M; Laitinen, JT; Nevalainen, T; Parkkari, T; Poso, A; Salo, OM; Savinainen, JR | 1 |
Buzard, DJ; Han, S; Jones, RM; Thatte, J | 1 |
Ihenetu, K; Molleman, A; Parsons, M; Whelan, C | 1 |
Ahn, KH; D'Antona, AM; Kendall, DA | 1 |
Arévalo-Martín, A; García-Ovejero, D; Gómez-Torres, O; Molina-Holgado, E; Molina-Holgado, F; Moore, JD; Rubio-Araiz, A; Williams, RJ | 1 |
Cristino, L; De Petrocellis, L; Di Marzo, V; Marini, P; Matias, I; Moriello, AS; Nigam, S; Starowicz, K | 1 |
Buckley, NE; Cabral, GA; Marciano-Cabral, F; Martin, BR; Raborn, ES | 1 |
Mahmud, A; Nagy, I; Paule, CC; Santha, P | 1 |
Gomez, O; Le, M; Molina-Holgado, E; Molina-Holgado, F; Sanchez-Caro, C; Sanchez-Rodriguez, A | 1 |
Ai, R; Chang, CE | 1 |
Fishbein-Kaminietsky, M; Gafni, M; Sarne, Y | 1 |
1 review(s) available for dronabinol and arachidonyl-2-chloroethylamide
Article | Year |
---|---|
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity | 2013 |
10 other study(ies) available for dronabinol and arachidonyl-2-chloroethylamide
Article | Year |
---|---|
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.
Topics: Animals; Cannabinoid Receptor Modulators; Cerebellum; GTP-Binding Proteins; In Vitro Techniques; Ligands; Male; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Radioligand Assay; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2006 |
Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.
Topics: Arachidonic Acids; Benzoxazines; Camphanes; Cell Survival; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Humans; Indoles; Interleukin-2; Leukocytes, Mononuclear; Morpholines; Naphthalenes; Phytohemagglutinins; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2003 |
Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization.
Topics: Amino Acid Sequence; Amino Acid Substitution; Arachidonic Acids; Benzoxazines; Cells, Cultured; Cyclic AMP; Dronabinol; Drug Stability; Guanosine 5'-O-(3-Thiotriphosphate); Hot Temperature; Humans; Kidney; Ligands; Morpholines; Mutation; Naphthalenes; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Threonine | 2006 |
CB2 cannabinoid receptors promote mouse neural stem cell proliferation.
Topics: Animals; Arachidonic Acids; Camphanes; Cell Division; Cells, Cultured; Cerebral Cortex; Dronabinol; Excitatory Amino Acid Antagonists; Lipoprotein Lipase; Mice; Neurons; Phosphatidylinositol 3-Kinases; Piperidines; Proto-Oncogene Proteins c-akt; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Signal Transduction; Spheroids, Cellular; Stem Cells | 2007 |
Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma beta-cells.
Topics: Animals; Arachidonic Acids; Bombesin; Calcium; Cannabinoids; Capsaicin; Cell Line, Tumor; Colforsin; Dose-Response Relationship, Drug; Dronabinol; Enzyme Inhibitors; Estrenes; Insulinoma; Neuroprotective Agents; Neurotransmitter Agents; Pertussis Toxin; Phosphoinositide Phospholipase C; Pyrrolidinones; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sensory System Agents; Signal Transduction; Thapsigargin; TRPV Cation Channels | 2007 |
The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor.
Topics: Animals; Arachidonic Acids; Camphanes; Chemokine CCL5; Chemotaxis; Cyclohexanols; Dronabinol; Female; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, CCR1; Receptors, CCR5; Receptors, G-Protein-Coupled; Rimonabant; RNA, Messenger; Signal Transduction | 2008 |
Cannabinoid 1 receptor activation inhibits transient receptor potential vanilloid type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons.
Topics: Animals; Arachidonic Acids; Bradykinin; Capsaicin; Cations, Divalent; Cells, Cultured; Cobalt; Dinoprostone; Dronabinol; Endocannabinoids; Female; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Sensory Receptor Cells; TRPV Cation Channels | 2009 |
Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.
Topics: Animals; Arachidonic Acids; Cannabinoids; Cell Differentiation; Cells, Cultured; Chromones; Dronabinol; Enzyme Activators; Indoles; Morpholines; Myelin Proteins; Oligodendroglia; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction; Sirolimus; Stem Cells; TOR Serine-Threonine Kinases | 2011 |
Ligand-specific homology modeling of human cannabinoid (CB1) receptor.
Topics: Amino Acid Sequence; Arachidonic Acids; Benzoxazines; Binding Sites; Dronabinol; Humans; Ligands; Molecular Docking Simulation; Molecular Sequence Data; Morpholines; Naphthalenes; Piperidines; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Adenosine A2; Receptors, Adrenergic, beta-2; Rhodopsin; Rimonabant; Sequence Alignment; Structural Homology, Protein; Structure-Activity Relationship; Thermodynamics | 2012 |
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage.
Topics: Anilides; Animals; Arachidonic Acids; Brain; Camphanes; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cognition Disorders; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Encephalitis; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; PPAR gamma; Pyrazoles; Recognition, Psychology | 2014 |